Literature DB >> 33513668

The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010-2017).

Mario J Olivera1,2, Francisco Palencia-Sánchez3, Martha Riaño-Casallas4.   

Abstract

BACKGROUND: Economic burden due to premature mortality has a negative impact not only in health systems but also in wider society. The aim of this study was to estimate the potential years of work lost (PYWL) and the productivity costs of premature mortality due to Chagas disease in Colombia from 2010 to 2017.
METHODS: National data on mortality (underlying cause of death) were obtained from the National Administrative Department of Statistics in Colombia between 2010 and 2017, in which Chagas disease was mentioned on the death certificate as an underlying or associated cause of death. Chagas disease as a cause of death corresponded to category B57 (Chagas disease) including all subcategories (B57.0 to B57.5), according to the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10). The electronic database contains the number of deaths from all causes by sex and 5-year age group. Economic data, including wages, unemployment rates, labor force participation rates and gross domestic product, were derived from the Bank of the Republic of Colombia. The human capital approach was applied to estimate both the PYWL and present value of lifetime income lost due to premature deaths. A discount rate of 3% was applied and results are presented in 2017 US dollars (USD).
RESULTS: There were 1261 deaths in the study, of which, 60% occurred in males. Premature deaths from Chagas resulted in 48,621 PYWL and a cost of USD 29 million in the present value of lifetime income forgone.
CONCLUSION: The productivity costs of premature mortality due to Chagas disease are significant. These results provide an economic measure of the Chagas burden which can help policy makers allocate resources to continue with early detection programs.

Entities:  

Keywords:  Chagas disease; cost of illness; efficiency; life expectancy; organizational; premature

Year:  2021        PMID: 33513668     DOI: 10.3390/tropicalmed6010017

Source DB:  PubMed          Journal:  Trop Med Infect Dis        ISSN: 2414-6366


  3 in total

1.  Cost-Effectiveness of the COVID-19 Test, Trace and Isolate Program in Colombia.

Authors:  Yenny Guzmán Ruiz; Andres I Vecino-Ortiz; Nicolás Guzman-Tordecilla; Rolando Enrique Peñaloza-Quintero; Julián A Fernández-Niño; Maylen Rojas-Botero; Fernando Ruiz Gomez; Sean D Sullivan; Antonio J Trujillo
Journal:  Lancet Reg Health Am       Date:  2021-11-01

2.  Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts.

Authors:  Mario J Olivera; Adriana Arévalo; Lyda Muñoz; Sofía Duque; Juan Bedoya; Gabriel Parra-Henao
Journal:  Ther Adv Infect Dis       Date:  2022-07-23

3.  Burden of Chronic Heart Failure in Romania.

Authors:  László Lorenzovici; Andrea Bârzan-Székely; Szabolcs Farkas-Ráduly; Bogdan C Pană; Marcell Csanádi; Nona Delia Chiriac; Zoltán Kaló
Journal:  Healthcare (Basel)       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.